Cyclic AMP-independent up-regulation of the human serotonin transporter by staurosporine in choriocarcinoma cells

J. D. Ramamoorthy, S. Ramamoorthy, Andreas Papapetropoulos, J. D. Catravas, F. H. Leibach, V. Ganapathy

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Treatment of confluent cultures of JAR human placental choriocarcinoma cells with staurosporine caused a marked stimulation of serotonin transport activity in these cells. The stimulatory effect was noticeable at nanomolar concentrations of staurosporine, and a treatment time of >4 h was required for staurosporine to elicit the effect. At 40 nM and with a treatment time of 16 h, the stimulation of the transport activity was 3.5-6.0-fold. None of the several other protein kinase inhibitors tested had similar effect except KT 5720, a protein kinase A inhibitor, which showed a small but significant (~1.4-fold) stimulatory effect at a concentration of 5 μM. Blockade of RNA synthesis and protein synthesis in the cells prevented completely the stimulation of the transport activity induced by staurosporine. The stimulation was observed not only in intact cells but also in plasma membrane vesicles prepared from staurosporine-treated cells. The stimulation was accompanied by a 5-7-fold increase in the steady state levels of the transporter-specific mRNAs, by a 7-fold increase in the maximal velocity of the transport process, and by a 6-fold increase in the transporter density in the plasma membrane. Even though both staurosporine and cholera toxin had similar effects on the serotonin transport activity in these cells, the effect was not additive when the cells were treated with both reagents together. While treatment of the cells with cholera toxin markedly elevated intracellular levels of cAMP, staurosporine did not have any effect on the cellular levels of this cyclic nucleotide. It is concluded that staurosporine up-regulates the serotonin transport activity in JAR cells by increasing the steady state levels of the serotonin transporter mRNA and by the consequent increase in the transporter density in the plasma membrane and that the process involves a cAMP-independent signaling pathway.

Original languageEnglish (US)
Pages (from-to)17189-17195
Number of pages7
JournalJournal of Biological Chemistry
Volume270
Issue number29
DOIs
StatePublished - Jan 1 1995
Externally publishedYes

Fingerprint

Serotonin Plasma Membrane Transport Proteins
Choriocarcinoma
Staurosporine
Cyclic AMP
Up-Regulation
Cell membranes
Serotonin
Cholera Toxin
Cell Membrane
Protein Kinase Inhibitors
Cells
Messenger RNA
Cyclic Nucleotides
Cyclic AMP-Dependent Protein Kinases
RNA

ASJC Scopus subject areas

  • Biochemistry

Cite this

Cyclic AMP-independent up-regulation of the human serotonin transporter by staurosporine in choriocarcinoma cells. / Ramamoorthy, J. D.; Ramamoorthy, S.; Papapetropoulos, Andreas; Catravas, J. D.; Leibach, F. H.; Ganapathy, V.

In: Journal of Biological Chemistry, Vol. 270, No. 29, 01.01.1995, p. 17189-17195.

Research output: Contribution to journalArticle

Ramamoorthy, J. D. ; Ramamoorthy, S. ; Papapetropoulos, Andreas ; Catravas, J. D. ; Leibach, F. H. ; Ganapathy, V. / Cyclic AMP-independent up-regulation of the human serotonin transporter by staurosporine in choriocarcinoma cells. In: Journal of Biological Chemistry. 1995 ; Vol. 270, No. 29. pp. 17189-17195.
@article{e02945fc5f124aba912fa9a8fe29a5a2,
title = "Cyclic AMP-independent up-regulation of the human serotonin transporter by staurosporine in choriocarcinoma cells",
abstract = "Treatment of confluent cultures of JAR human placental choriocarcinoma cells with staurosporine caused a marked stimulation of serotonin transport activity in these cells. The stimulatory effect was noticeable at nanomolar concentrations of staurosporine, and a treatment time of >4 h was required for staurosporine to elicit the effect. At 40 nM and with a treatment time of 16 h, the stimulation of the transport activity was 3.5-6.0-fold. None of the several other protein kinase inhibitors tested had similar effect except KT 5720, a protein kinase A inhibitor, which showed a small but significant (~1.4-fold) stimulatory effect at a concentration of 5 μM. Blockade of RNA synthesis and protein synthesis in the cells prevented completely the stimulation of the transport activity induced by staurosporine. The stimulation was observed not only in intact cells but also in plasma membrane vesicles prepared from staurosporine-treated cells. The stimulation was accompanied by a 5-7-fold increase in the steady state levels of the transporter-specific mRNAs, by a 7-fold increase in the maximal velocity of the transport process, and by a 6-fold increase in the transporter density in the plasma membrane. Even though both staurosporine and cholera toxin had similar effects on the serotonin transport activity in these cells, the effect was not additive when the cells were treated with both reagents together. While treatment of the cells with cholera toxin markedly elevated intracellular levels of cAMP, staurosporine did not have any effect on the cellular levels of this cyclic nucleotide. It is concluded that staurosporine up-regulates the serotonin transport activity in JAR cells by increasing the steady state levels of the serotonin transporter mRNA and by the consequent increase in the transporter density in the plasma membrane and that the process involves a cAMP-independent signaling pathway.",
author = "Ramamoorthy, {J. D.} and S. Ramamoorthy and Andreas Papapetropoulos and Catravas, {J. D.} and Leibach, {F. H.} and V. Ganapathy",
year = "1995",
month = "1",
day = "1",
doi = "10.1074/jbc.270.29.17189",
language = "English (US)",
volume = "270",
pages = "17189--17195",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "29",

}

TY - JOUR

T1 - Cyclic AMP-independent up-regulation of the human serotonin transporter by staurosporine in choriocarcinoma cells

AU - Ramamoorthy, J. D.

AU - Ramamoorthy, S.

AU - Papapetropoulos, Andreas

AU - Catravas, J. D.

AU - Leibach, F. H.

AU - Ganapathy, V.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Treatment of confluent cultures of JAR human placental choriocarcinoma cells with staurosporine caused a marked stimulation of serotonin transport activity in these cells. The stimulatory effect was noticeable at nanomolar concentrations of staurosporine, and a treatment time of >4 h was required for staurosporine to elicit the effect. At 40 nM and with a treatment time of 16 h, the stimulation of the transport activity was 3.5-6.0-fold. None of the several other protein kinase inhibitors tested had similar effect except KT 5720, a protein kinase A inhibitor, which showed a small but significant (~1.4-fold) stimulatory effect at a concentration of 5 μM. Blockade of RNA synthesis and protein synthesis in the cells prevented completely the stimulation of the transport activity induced by staurosporine. The stimulation was observed not only in intact cells but also in plasma membrane vesicles prepared from staurosporine-treated cells. The stimulation was accompanied by a 5-7-fold increase in the steady state levels of the transporter-specific mRNAs, by a 7-fold increase in the maximal velocity of the transport process, and by a 6-fold increase in the transporter density in the plasma membrane. Even though both staurosporine and cholera toxin had similar effects on the serotonin transport activity in these cells, the effect was not additive when the cells were treated with both reagents together. While treatment of the cells with cholera toxin markedly elevated intracellular levels of cAMP, staurosporine did not have any effect on the cellular levels of this cyclic nucleotide. It is concluded that staurosporine up-regulates the serotonin transport activity in JAR cells by increasing the steady state levels of the serotonin transporter mRNA and by the consequent increase in the transporter density in the plasma membrane and that the process involves a cAMP-independent signaling pathway.

AB - Treatment of confluent cultures of JAR human placental choriocarcinoma cells with staurosporine caused a marked stimulation of serotonin transport activity in these cells. The stimulatory effect was noticeable at nanomolar concentrations of staurosporine, and a treatment time of >4 h was required for staurosporine to elicit the effect. At 40 nM and with a treatment time of 16 h, the stimulation of the transport activity was 3.5-6.0-fold. None of the several other protein kinase inhibitors tested had similar effect except KT 5720, a protein kinase A inhibitor, which showed a small but significant (~1.4-fold) stimulatory effect at a concentration of 5 μM. Blockade of RNA synthesis and protein synthesis in the cells prevented completely the stimulation of the transport activity induced by staurosporine. The stimulation was observed not only in intact cells but also in plasma membrane vesicles prepared from staurosporine-treated cells. The stimulation was accompanied by a 5-7-fold increase in the steady state levels of the transporter-specific mRNAs, by a 7-fold increase in the maximal velocity of the transport process, and by a 6-fold increase in the transporter density in the plasma membrane. Even though both staurosporine and cholera toxin had similar effects on the serotonin transport activity in these cells, the effect was not additive when the cells were treated with both reagents together. While treatment of the cells with cholera toxin markedly elevated intracellular levels of cAMP, staurosporine did not have any effect on the cellular levels of this cyclic nucleotide. It is concluded that staurosporine up-regulates the serotonin transport activity in JAR cells by increasing the steady state levels of the serotonin transporter mRNA and by the consequent increase in the transporter density in the plasma membrane and that the process involves a cAMP-independent signaling pathway.

UR - http://www.scopus.com/inward/record.url?scp=0029154207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029154207&partnerID=8YFLogxK

U2 - 10.1074/jbc.270.29.17189

DO - 10.1074/jbc.270.29.17189

M3 - Article

C2 - 7615516

AN - SCOPUS:0029154207

VL - 270

SP - 17189

EP - 17195

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 29

ER -